Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical Trials
Authors:
- 12 March 2014
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 95 (6) , 617-626
Abstract
Adherence to rationally prescribed medications is essential for effective pharmacotherapy. However, widely variable adherence to protocol-specified dosing regimens is prevalent among participants in ambulatory drug trials, mostly manifested in the form of underdosing. Drug actions are inherently dose and time dependent, and as a result, variable underdosing diminishes the actions of trial medications by various degrees. The ensuing combination of increased variability and decreased magnitude of trial drug actions reduces statistical power to discern between-group differences in drug actions. Variable underdosing has many adverse consequences, some of which can be mitigated by the combination of reliable measurements of ambulatory patients' adherence to trial and nontrial medications, measurement-guided management of adherence, statistically and pharmacometrically sound analyses, and modifications in trial design. Although nonadherence is prevalent across all therapeutic areas in which the patients are responsible for treatment administration, the significance of the adverse consequences depends on the characteristics of both the disease and the medications.Keywords
This publication has 63 references indexed in Scilit:
- Medication Adherence AssessmentTransplantation, 2013
- Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-AnalysisDrugs, 2013
- Preexposure Prophylaxis for HIV Infection among African WomenNew England Journal of Medicine, 2012
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- The Secrets of a Successful Clinical Trial: Compliance, Compliance, and ComplianceMolecular Interventions, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatmentsBiostatistics, 2010
- Deconstructing the Drug Development Process: The New Face of InnovationClinical Pharmacology & Therapeutics, 2010
- Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ, 2008